ClinConnect ClinConnect Logo
Search / Trial NCT06325449

Correlating Improvement in PCOS Symptoms to the Percentage of Body Weight Lost in Females Also Living With Obesity

Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Mar 15, 2024

Trial Information

Current as of August 19, 2025

Not yet recruiting

Keywords

Polycystic Ovary Syndrome Obesity Endocrine Noncommunicable Diseases Surveys And Questionnaires Metabolic Disease Insulin Sensitivity

ClinConnect Summary

This clinical trial is looking at how a special weight loss program, called STREAM, can help women with Polycystic Ovary Syndrome (PCOS) who are also living with obesity. The main goal is to see how much weight these women can lose in 24 weeks and if losing weight can improve their overall health, particularly how their bodies handle insulin, which is important for managing blood sugar levels.

To participate, women need to be at least 18 years old, have a body mass index (BMI) of 30 or higher, or 27 or higher if they have weight-related health issues. They should also speak English and be referred to the LEAF Weight Management Clinic. During the 24-week program, participants will weigh themselves regularly, have blood tests to check their health, and fill out surveys about their quality of life. It’s important to note that women who have had certain weight loss surgeries, are currently taking specific medications, or are pregnant may not be eligible for this study. This trial is not yet recruiting participants, so there will be more information to come.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Pre-menopausal female ≥ 18 years old
  • BMI ≥ 30 kg/m2 or ≥ 27 kg/m2 with adiposity-related complications
  • English proficiency
  • Referral to LEAF Weight Management Clinic
  • Exclusion Criteria:
  • Previous bariatric surgery
  • Currently on OCP or using an IUD
  • Currently using a pharmacotherapy with an impact on weight (Liraglutide, Semaglutide, Tirzepatide, Naltrexone/Buproprion, Orlistat)
  • Currently pregnant
  • Currently using an androgen supplement (Testosterone, DHEAS)

About Ottawa Hospital Research Institute

The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.

Locations

Ottawa, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Judy Shiau, MD

Principal Investigator

The Ottawa Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported